Rafferty Asset Management’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$820K Sell
2024
Q2
$858K Sell
2024
Q1
$6.81M Buy
2023
Q1
Sell
2022
Q4
$1.05M Buy
2022
Q3
$988K Buy
2022
Q2
Sell
2022
Q1
$3.29M Buy
2021
Q4
$2.96M Buy
2021
Q3
$2.64M Buy
2021
Q2
$1.85M Buy
2021
Q1
$1.74M Buy